The pharmaceuticals company recommended paying out a gross dividend of RON0.023 per share, up from RON0.018 per share distributed last year.
Thursday, Antibiotice closed at RON0.59 a share, down 1.67% on the day.
The proposal will be discussed at a shareholder meeting scheduled for April 24.
Antibiotice is majority-owned by Romania’s Health Ministry, with a 53.02% stake, while investment fund SIF Oltenia (SIF5.RO) holds a 10.32% stake.
The company reported a 16% increase in its net profit to RON31.4 million in 2013, from RON27.1 million in the previous year. The figure is slightly higher than RON28.8 million announced in a preliminary report last month.
Antibiotice proposed retaining RON11 million from last year’s profit to replenish its resources, while RON3.1 million will be used to finance various investments. (EUR1=RON4.4816)